How has Rubius Therapeutics, Inc.'s stock price performed over the past year?

Question

Accepted Answer

Rubius Therapeutics, Inc.'s stock has declined approximately -77.55906% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.02.

Beta (5Y)	N/A
52-Week Price Change	-77.55906%
50-Day Moving Average	0.02
200-Day Moving Average	0.02
Average Volume (20 Days)	N/A

Rubius Therapeutics, Inc.

Stock Price Statistics